Trial intelligence / Profile preview

Remimazolam versus propofol for anesthesia induction hemodynamics in geriatric major abdominal surgery

ChiCTR2200065529Phase 4Not yet recruiting

Sponsor
Fujian Provincial Hospital
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial comparing remimazolam with propofol (2 arms). Primary endpoint: Area under the baseline mean arterial pressure over the first 15 minutes after induction. Planned start Nov 2022; status: not yet recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2200065529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200065529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call